Literature DB >> 22474329

A comparative study of stress-mediated immunological functions with the adjuvanticity of alum.

Yufei Wang1, Durdana Rahman, Thomas Lehner.   

Abstract

The efficacy of a vaccine is generally dependent on an adjuvant, which enhances the immune functions and alum has been widely used in human immunization. Alum activates the intracellular stress sensors inflammasomes, but whether these are responsible for the adjuvanticity is controversial. The objectives of this investigation were to examine the hypothesis that alum-mediated adjuvanticity is a function of stress and conversely that stress agents will elicit adjuvanticity. The investigation was carried out in BALB/c mice by SC immunization with ovalbumin (OVA) mixed with alum. This elicited inflammasomes, with significant activation of caspase 1, production of IL-1β, and adjuvanticity, demonstrated by enhancing OVA-specific serum IgG antibodies, CD4(+) T cells, and proliferation. The novel finding that alum induced HSP70 suggests that stress is involved in the mechanism of adjuvanticity. This was confirmed by inhibition studies with PES (phenylethynesulfonamide), which disrupts inducible HSP70 function, and inhibited both inflammasomes and the adjuvant function. Parallel studies were pursued with an oxidative agent (sodium arsenite), K-releasing agent (Gramicidin) and a metal ionophore (dithiocarbamate). All 3 stress agents induced HSP70, inflammasomes, and the adjuvant functions. Furthermore, up-regulation of membrane associated IL-15 on DC and CD40L on T cells in the animals treated with alum or the stress agents mediate the interactions between splenic CD11c DC and CD4(+) or CD8(+) T cells. The results suggest that the three stress agents elicit HSP70, a hallmark of stress, as well as inflammasomes and adjuvanticity, commensurate with those of alum, which may provide an alternative strategy in developing novel adjuvants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22474329      PMCID: PMC3366808          DOI: 10.1074/jbc.M112.347179

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Reactive oxygen species activate human peripheral blood dendritic cells.

Authors:  K Rutault; C Alderman; B M Chain; D R Katz
Journal:  Free Radic Biol Med       Date:  1999-01       Impact factor: 7.376

3.  Mycobacterial heat-shock proteins as carrier molecules.

Authors:  A R Lussow; C Barrios; J van Embden; R Van der Zee; A S Verdini; A Pessi; J A Louis; P H Lambert; G Del Giudice
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

Review 4.  Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation.

Authors:  Sanjeev Mariathasan; Denise M Monack
Journal:  Nat Rev Immunol       Date:  2007-01       Impact factor: 53.106

5.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Babak Baban; Heather P Harding; Yuhong Zhang; David Ron; Andrew L Mellor
Journal:  Immunity       Date:  2005-05       Impact factor: 31.745

6.  Mycobacterial heat-shock proteins as carrier molecules. II: The use of the 70-kDa mycobacterial heat-shock protein as carrier for conjugated vaccines can circumvent the need for adjuvants and Bacillus Calmette Guérin priming.

Authors:  C Barrios; A R Lussow; J Van Embden; R Van der Zee; R Rappuoli; P Costantino; J A Louis; P H Lambert; G Del Giudice
Journal:  Eur J Immunol       Date:  1992-06       Impact factor: 5.532

7.  Induction of cellular stress overcomes the requirement of herpes simplex virus type 1 for immediate-early protein ICP0 and reactivates expression from quiescent viral genomes.

Authors:  Chris M Preston; Mary Jane Nicholl
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

8.  CD11c expression identifies a population of extrafollicular antigen-specific splenic plasmablasts responsible for CD4 T-independent antibody responses during intracellular bacterial infection.

Authors:  Rachael Racine; Madhumouli Chatterjee; Gary M Winslow
Journal:  J Immunol       Date:  2008-07-15       Impact factor: 5.422

9.  Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.

Authors:  Anja Seubert; Samuele Calabro; Laura Santini; Barbara Galli; Alessia Genovese; Sara Valentini; Susanna Aprea; Annalisa Colaprico; Ugo D'Oro; Marzia M Giuliani; Michele Pallaoro; Mariagrazia Pizza; Derek T O'Hagan; Andreas Wack; Rino Rappuoli; Ennio De Gregorio
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

10.  Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity.

Authors:  Amy S McKee; Michael W Munks; Megan K L MacLeod; Courtney J Fleenor; Nico Van Rooijen; John W Kappler; Philippa Marrack
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

View more
  18 in total

Review 1.  Key roles of adjuvants in modern vaccines.

Authors:  Steven G Reed; Mark T Orr; Christopher B Fox
Journal:  Nat Med       Date:  2013-12-05       Impact factor: 53.440

2.  MyD88 in antigen-presenting cells is not required for CD4+ T-cell responses during peptide nanofiber vaccination.

Authors:  Youhui Si; Yi Wen; Jianjun Chen; Rebecca R Pompano; Huifang Han; Joel Collier; Anita S Chong
Journal:  Medchemcomm       Date:  2017-11-29       Impact factor: 3.597

Review 3.  Clinical vaccine development for H5N1 influenza.

Authors:  Christopher H Clegg; Joseph A Rininger; Susan L Baldwin
Journal:  Expert Rev Vaccines       Date:  2013-07       Impact factor: 5.217

4.  Disparate adjuvant properties among three formulations of "alum".

Authors:  Derek W Cain; Sergio E Sanders; Michael M Cunningham; Garnett Kelsoe
Journal:  Vaccine       Date:  2012-11-29       Impact factor: 3.641

5.  Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.

Authors:  Emilie Seydoux; Hong Liang; Natasha Dubois Cauwelaert; Michelle Archer; Nicholas D Rintala; Ryan Kramer; Darrick Carter; Christopher B Fox; Mark T Orr
Journal:  J Immunol       Date:  2018-05-16       Impact factor: 5.422

6.  Exposure to inhomogeneous static magnetic field beneficially affects allergic inflammation in a murine model.

Authors:  Anikó Csillag; Brahma V Kumar; Krisztina Szabó; Mária Szilasi; Zsuzsa Papp; Magdolna E Szilasi; Kitti Pázmándi; István Boldogh; Éva Rajnavölgyi; Attila Bácsi; János F László
Journal:  J R Soc Interface       Date:  2014-03-19       Impact factor: 4.118

7.  Stress-activated Dendritic Cells (DC) Induce Dual Interleukin (IL)-15- and IL1β-mediated Pathways, Which May Elicit CD4+ Memory T Cells and Interferon (IFN)-stimulated Genes.

Authors:  Yufei Wang; Paul Lavender; Julie Watson; Matthew Arno; Thomas Lehner
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

8.  The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors:  Tirth Raj Ghimire
Journal:  Springerplus       Date:  2015-04-16

Review 9.  Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective.

Authors:  Silke Neumann; Nicholas J Shields; Thomas Balle; Mary Chebib; Andrew N Clarkson
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

10.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.